《盈喜》金斯瑞(01548.HK)录一次性收益 预计全年净利润大增

阿斯达克财经
16 Feb

金斯瑞生物科技(01548.HK) 发盈喜,预计2024年度净利润将较2023年度有重大增长。综合原因包括︰视作出售传奇生物的一次性未实现收益约32亿美元;及蓬勃A类和C类优先股公允价值变动带来非现金公允价值亏损约1.24亿美元。从非细胞疗法业务角度,及剔除以上两项影响,期内经调整净利润保持稳定,未发生重大变化。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-14 16:25。)

过往派息
公布日期派息事项派息内容
2024/08/09中期业绩无派息
2024/03/10末期业绩无派息
2023/08/20中期业绩无派息
2023/03/31末期业绩无派息

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10